News Medical on MSN

Novel liquid biopsy technology lowers barriers for more efficient cancer diagnostics

A novel liquid biopsy technology is set to advance cancer diagnostics and monitoring by overcoming the long-standing ...
AdnKronos

Volta Labs Launches Automated Twist Hybridization Capture Workflow on Callisto

BOSTON, Oct. 9, 2025 /PRNewswire/ -- Volta Labs, the pioneer in next-generation sequencing (NGS) sample preparation solutions, today announced the launch of Hybridization Capture App for the Twist ...
Business Wire

Element Biosciences Launches Trinity™ – A Revolutionary Targeted Sequencing Innovation to Streamline Genomic Research

SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., a developer of pioneering technologies to empower science, today introduced Trinity™ - an innovative solution that simplifies target capture ...
technologynetworks

A complete workflow from sample preparation to analysis using SureSelect target enrichment system for Ion Proton semiconductor sequencing

Whole exome or targeted sequencing for protein-coding regions has provided a cost effective way to identify common and rare polymorphisms that are associated with Mendelian disorders and complex ...
BioTechniques

A workflow for whole-genome sequencing of bacterial isolates

Whole-genome sequencing of microbial isolates provides valuable information for public health, clinical microbiology research, food safety and microbial ecology. Nanopore sequencing offers distinct ...
Insider Monkey

Twist and Element Biosciences Expands Pact for Sequencing Workflow Solutions

Twist Bioscience Corporation (NASDAQ:TWST) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds. The firm has expanded its relationship with Element Biosciences to produce end-to-end ...
Business Wire

Twist Bioscience and Element Biosciences Advance Collaboration with Launch of New Trinity Freestyle™ Sequencing Workflow for the AVITI™ System

SOUTH SAN FRANCISCO, Calif. & SAN DIEGO--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, and Element Biosciences, Inc., a company ...